Remarkably, we found that both complete as well as monoallelic (partial) loss of Ppp2r5d not only accelerated DEN-induced HCC development, but also resulted in the unusual development of combined HCC-CCA tumors in this model, at a later stage of the disease. The gene discussed is PPP2R5D; the disease is cholangiocarcinoma.